S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ATAI ATAI Life Sciences NV

1.64

0.03 (1.86%)

Pre Market

Last Updated: 03:49:28

Delayed by 15 minutes

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more ATAI Life Sciences NV Charts.

ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more ATAI Life Sciences NV Charts.

ATAI Life Sciences NV News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (13 hours ago) • Edgar (US Regulatory)

atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression
Wednesday 5 March 2025 (23 hours ago) • GlobeNewswire Inc.

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Monday 24 February 2025 (1 week ago) • Edgar (US Regulatory)

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference
Monday 24 February 2025 (1 week ago) • GlobeNewswire Inc.

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
Thursday 20 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 13 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 13 February 2025 (3 weeks ago) • Edgar (US Regulatory)

atai Life Sciences Announces Pricing of Public Offering of Common Shares
Wednesday 12 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 12 February 2025 (3 weeks ago) • Edgar (US Regulatory)

atai Life Sciences Announces Proposed Public Offering of Common Shares
Wednesday 12 February 2025 (3 weeks ago) • GlobeNewswire Inc.

atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder
Tuesday 28 January 2025 (1 month ago) • GlobeNewswire Inc.

More ATAI Life Sciences NV News Articles

Accredited Solutions (PK)

NioCorp Developments

Bell Buckle (PK)

Good Vibrations Shoes (PK)

Code Green Apparel (PK)

Asia Broadband (PK)

RespireRx Pharmaceuticals (CE)

Bioelectronics (PK)

Impact Fusion (PK)

Voip Pal Com (QB)

AMC Entertainment

Cann American (CE)

Adia Nutrition (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions